DOSAGE REGIMES FOR THE ADMINISTRATION OF A LAG-3/PD-L1 BISPECIFIC ANTIBODY

The application relates to dosage regimes for the administration of an antibody molecule which binds programmed death-ligand 1 (PD-L1) and lymphocyte-activation gene 3 (LAG-3) and their medical use in the treatment of cancer in human patients. L'invention concerne des régimes posologiques pour...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	KAYITALIRE, LOUIS, SHEPHERD, CHRISTOPHER, HOLZ, JOSEFIN-BEATE, MORROW, MICHELLE, GERMASCHEWSKI, FIONA, LEUNG, KIN-MEI, GLIDDON, DANIEL, GRADINARU, CRISTIAN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!